1 / 20

Competitive Analysis and Market Research Capabilities

This presentation describes PharmaForce five powerful web-based programs that allow clients to access up-to-date information on leading pharmaceutical sales forces around the globe. These easy-to-use database-driven programs are constantly being updated and provide valuable knowledge on leading companies’ sales forces in the United States, Japan, India, ten countries in Europe and three countries in Latin America.

pharmaforce
Télécharger la présentation

Competitive Analysis and Market Research Capabilities

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Competitive Analysis andMarket Research Capabilities 2013

  2. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES About PharmaForce International Global leaders in identifying “everything and anything” that pharmaceutical and biotech companies want to know about the operations of their competitors Specialists in competitive intelligence for the pharmaceutical, biotech and medical device industries • Competitive Monitoring • Syndicated Studies • Proprietary Projects 1 Copyright 2013 by PharmaForce International R E A D I N G, P A

  3. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES About PharmaForce International (cont’d) • Multi-lingual staff with direct experience in the pharmaceutical industry and business intelligence • Hundreds of years of combined industry experience as Sales Representatives, District Managers, Product Managers, Medical Information Specialists, Market Research Directors, Clinical Trial Coordinators, Business Analysts, Medical Liaisons and Country Business Unit Directors • Primary research capabilities, including the following languages: - Arabic - Italian - Chinese - Japanese - Croatian - Mandarin - Dutch - Portuguese - English - Russian - French - Serbian - German - Slovenian - Hindi - Spanish 2 Copyright 20123by PharmaForce International R E A D I N G, P A

  4. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Examples of Countries Where PharmaForce Conducts Research 3 Copyright 2013 by PharmaForce International R E A D I N G, P A

  5. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Selection of PharmaForce International‘s Clients 4 Copyright 2013 by PharmaForce International R E A D I N G, P A

  6. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES PharmaForce’s 360 Program • PharmaForce specializes in providing clients with a 360 perspective on the marketplace for their drugs 5 Copyright 2013 by PharmaForce International R E A D I N G, P A

  7. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES PharmaForce’s 360 Program (cont’d) • Pick and choose from the capabilities menu or receive tremendous cost savings by packaging a full suite of service • Our competitive intelligence capabilities track strategic planning through brand/ market assessments as well as therapeutic area outlooks 6 Copyright 2013 by PharmaForce International R E A D I N G, P A

  8. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Research Techniques • Unique combination of field research methodologies can be utilized in any therapeutic area(s) • Unstructured peer interviews conducted by professional staff • Questionnaire web-based surveys • Highly detailed benchmarking questionnaires • Expert panels • Through these survey techniques, PharmaForce has the ability to rapidly develop product and commercial strategy perceptions from key customer constituencies, such as: • KOLs • Physicians • High prescribers 7 Copyright 2013 by PharmaForce International R E A D I N G, P A

  9. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Field-Tested Primary Source Research Approach • More than 90% of the information for any project is derived from one-on-one interviews with individuals in the industry • Includes current and former employees of target organizations • Interviewers draw a common bond with interview targets and engage in peer-to-peer discussions about topics of common interest • Supplemented with searches of all relevant electronic and printed databases, including PharmaForce’s proprietary databases developed over the past two decades Database of qualified contacts in the pharmaceutical industry exceeds 50,000 worldwide • Includes personnel in almost every sales and marketing function from sales representatives to senior management 8 Copyright 2013 by PharmaForce International R E A D I N G, P A

  10. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Field-Tested Primary Source Research Approach (cont’d) • All employees participate in an ongoing training program to improve interviewing techniques and identify the latest trends in the industry • Member of PBIRG and EphMRA 9 Copyright 2013 by PharmaForce International R E A D I N G, P A

  11. Target company Competitors Former employees Clinical trial investigators Formulary managers Advertising agencies Physicians, thought leaders, hospitals and other medical personnel Advocacy and cooperative groups, convention personnel, CME development firms, etc. Existing database COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Interviewing Methodology 10 Copyright 2013 by PharmaForce International R E A D I N G, P A

  12. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Competitive Advantages of Using PharmaForce • Key competitive advantages of utilizing PharmaForce for your competitive analysis and market research needs include: • Pharmaindustry-experienced staff who are veterans of hundreds of projects in the pharmaceutical and biotech industries • One-on-one interviewing with KOLs, physicians and patients to obtain the full perspective on your therapeutic area • Customized reports available to target any company, country, therapy area and brand of interest! • Established relationships with over 50,000 industry personnel to gain crucial insights on your key competitors • 360° view into internal structures, market spending, insights, benchmarks and best practices of industry leaders worldwide 11 Copyright 2013 by PharmaForce International R E A D I N G, P A

  13. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Why Companies Use PharmaForce’s Studies • Overall, PharmaForce’s studies provide more information to better deploy resources 12 Copyright 2013 by PharmaForce International R E A D I N G, P A

  14. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Client Testimonials • “Your oncology sales force and marketing expenditure benchmarking is the gold standard in the industry. Our company has purchased the study for 6 consecutive years and could not determine our marketing budgets or sales force POAs without it” • Global Market Research Director, Top 5 Pharma Company • “PharmaForce’s competitive intelligence data is by far the most accurate data that we have ever used. Senior management love it. We would not use any other competitive intelligence firm” • Market Intelligence Director, Billion Dollar Specialty Pharma Company • “Once we used PharmaForce’s benchmarking data in one therapeutic area, I immediately knew that we had to use it in every other therapeutic area in our company” • Director, Global Market Analytics, Top 10 PharmaCompany • “PharmaForceworks within this company’s budget constraints to provide partial data from multiple syndicated studies” • Up-and-coming biotech company launching its first drug 13 Copyright 2013 by PharmaForce International R E A D I N G, P A

  15. COMPETITIVE ANALYSIS AND MARKET RESEARCH CAPABILITIES Examples of Types of Studies Conducted by PharmaForce • Assisting an Emerging Biotech Assess the Competitive Landscape for the First Time and Develop Recommendations for Establishing a Commercial Presence in 6Different Countries Worldwide • Benchmarking of Marketing Expenditures by Product or Franchise • Analysis of Drug Launch Plans • Assessment of Potential Biotech Partnership/Acquisition Opportunities • Competitive Assessment of Patient Marketing Programs and Materials • Analysis of Medical Services Departments Globally • Health Economics Outcomes Research (HEOR) Strategies • Benchmarking of the Managed Care Function at Leading Pharma Companies • Assessment of KOL Opinions on Best Practices in Advisory Board Sessions • Competitive Monitoring of the U.S. Vaccines Market • Analysis of Clinical Trial and Phase IV Strategies for Select Products • Analysis of Sampling Programs and Detailing Messages • Benchmarking of the Medical Affairs Function Supporting Leading Products • Benchmarking of Speakers’ Bureaus and Advisory Board Management • Competitive Benchmarking of Leading Pharmaceutical Companies’ Strategies for Targeting the Hospital/IDN Market Customer 14 Copyright 2013 by PharmaForce International R E A D I N G, P A

  16. OVERALL ASSESSMENT 15

  17. OVERALL ASSESSMENT List of Syndicated Studies • PharmaForce International Global Deployment Analyzer: a powerful web-based program that allow clients to access up-to-date information on leading pharmaceutical sales forces around the globe at www.deploymentanalyzer.com • 60 leading companies’ sales forces in the United States • 25 leading companies’ sales forces in 10 countries in Europe • 25 leading companies’ sales forces in Japan • 12 leading companies’ sales forces in Argentina, Brazil and Mexico • 13 leading companies’ sales forces in India • Competitive Benchmarking of Leading Oncology Sales and Marketing Organizations, providing worldwide perspective on sales and marketing operations of leading oncology competitors around the globe • 14 leading companies in 5 countries in Europe • 21 leading companies in the United States • 11 leading companies in Japan • 10 leading companies in 4 countries in Latin America 16 Copyright 2013 by PharmaForce International R E A D I N G, P A

  18. OVERALL ASSESSMENT List of Syndicated Studies (cont’d) • Competitive Benchmarking of Leading Multiple Sclerosis Sales and Marketing Organizations, covering commercial operations of each leading franchise that competes in this dynamic specialty market • 5 leading companies in 5 countries in Europe • 5 leading companies in the United States • Competitive Benchmarking of Leading Hepatitis Sales and Marketing Organizations in the United States, Europe and Japan • Competitive Benchmarking of Leading Anti-TNF/Immunology Sales and Marketing Organizations: Key Expenditures and Organizational Approaches in the United States • Competitive Benchmarking of Leading Pharmaceutical Companies’ Strategies for Leveraging the Medical Liaison Function in the United States and Europe 17 Copyright 2013 by PharmaForce International R E A D I N G, P A

  19. OVERALL ASSESSMENT List of Syndicated Studies (cont’d) • Managed Markets Structures and Strategies: Leading Companies’ Approaches • Integrated Delivery Networks (IDNs): Analysis of Leading Pharmaceutical Companies • Competitive Benchmarking of Leading Pharmaceutical Companies’ Strategies for Leveraging Health Economics Outcomes Research (HEOR) Capabilities 18 Copyright 2013 by PharmaForce International R E A D I N G, P A

  20. THANK YOU Contact Me For more information about PharmaForce International and our Global Sales Force Deployment Analyzer database, please contact Allison Becker or Marija Jukic at: 1-610-370-5640 or abecker@pharmaforce.biz mjukic@pharmaforce.biz 19 Copyright 2013 by PharmaForce International R E A D I N G, P A

More Related